Evaluation of four commercial severe acute respiratory coronavirus 2 antibody tests.
Ashizawa N, Takazono T, Ohyama K, Nagasaki Y, Okamoto M, Hirayama T, Takahashi K, Yamanashi H, Tashiro M, Hosogaya N, Tanaka T, Yamamoto K, Fukuda Y, Imamura Y, Kawanami T, Miyazaki T, Sawai T, Fukushima K, Yatera K, Yanagihara K, Izumikawa K, Mukae H.
Ashizawa N, et al.
J Infect Chemother. 2021 Jul;27(7):1033-1038. doi: 10.1016/j.jiac.2021.03.008. Epub 2021 Mar 15.
J Infect Chemother. 2021.
PMID: 33781691
Free PMC article.